References
- Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D (2011) Global cancer statistics. CA Cancer J Clin 61, 69-90 https://doi.org/10.3322/caac.20107
- O'Brien KM, Cole SR, Tse CK et al (2010) Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 16, 6100-6110 https://doi.org/10.1158/1078-0432.CCR-10-1533
- Perou CM (2011) Molecular stratification of triple-negative breast cancers. Oncologist 16 Suppl 1, 61-70 https://doi.org/10.1634/theoncologist.2011-S1-61
- Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295, 2492-2502 https://doi.org/10.1001/jama.295.21.2492
- Jones PA and Baylin SB (2007) The epigenomics of cancer. Cell 128, 683-692 https://doi.org/10.1016/j.cell.2007.01.029
- Chen X, Hu H, He L et al (2016) A novel subtype classification and risk of breast cancer by histone modification profiling. Breast Cancer Research and Treatment 157, 267-279 https://doi.org/10.1007/s10549-016-3826-8
- Koch CM, Andrews RM, Flicek P et al (2007) The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res 17, 691-707 https://doi.org/10.1101/gr.5704207
- Barski A, Cuddapah S, Cui K et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 https://doi.org/10.1016/j.cell.2007.05.009
- Xi Y, Shi J, Li W et al (2018) Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes. BMC Genomics 19, 150 https://doi.org/10.1186/s12864-018-4533-0
- Gomez-Cabrero D, Abugessaisa I, Maier D et al (2014) Data integration in the era of omics: current and future challenges. BMC Syst Biol 8 Suppl 2, I1 https://doi.org/10.1186/1752-0509-8-S2-I1
- Chaligne R, Popova T, Mendoza-Parra MA et al (2015) The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer. Genome Res 25, 488-503 https://doi.org/10.1101/gr.185926.114
- Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45, W98-W102 https://doi.org/10.1093/nar/gkx247
- Nebbioso A, Tambaro FP, Dell'Aversana C and Altucci L (2018) Cancer epigenetics: Moving forward. PLoS Genet 14, e1007362 https://doi.org/10.1371/journal.pgen.1007362
- Zand B, Previs RA, Zacharias NM et al (2016) Role of Increased n-acetylaspartate Levels in Cancer. J Natl Cancer Inst 108, djv426 https://doi.org/10.1093/jnci/djv426
- Sun C, Ban Y, Wang K, Sun Y and Zhao Z (2019) SOX5 promotes breast cancer proliferation and invasion by transactivation of EZH2. Oncol Lett 17, 2754-2762
- Wolf J, Muller-Decker K, Flechtenmacher C et al (2014) An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation. Oncogene 33, 4273-4278 https://doi.org/10.1038/onc.2013.515
- Ma C, Wang F, Han B et al (2018) SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex. Mol Cancer 17, 78 https://doi.org/10.1186/s12943-018-0824-y
- Rahman M, Jackson LK, Johnson WE, Li DY, Bild AH and Piccolo SR (2015) Alternative preprocessing of RNASequencing data in The Cancer Genome Atlas leads to improved analysis results. Bioinformatics 31, 3666-3672 https://doi.org/10.1093/bioinformatics/btv377